“Lipid Hybrid Nanoparticles in Cancer Therapy: A Promising Nanotechnology-Based Drug Delivery System” (2025) International Journal of Pharmaceutical Sciences and Drug Research, 17(4), pp. 371–387. doi:10.25004/IJPSDR.2025.170408.